
Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
Publication
, Journal Article
Lopes, RD; de Barros E Silva, PGM; Furtado, RHM; Alexander, JH; Berwanger, O
Published in: Lancet
October 9, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 9, 2021
Volume
398
Issue
10308
Start / End Page
1304
Location
England
Related Subject Headings
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Fibrin Fibrinogen Degradation Products
- COVID-19
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lopes, R. D., de Barros E Silva, P. G. M., Furtado, R. H. M., Alexander, J. H., & Berwanger, O. (2021). Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply. Lancet, 398(10308), 1304. https://doi.org/10.1016/S0140-6736(21)01909-7
Lopes, Renato D., Pedro Gabriel Melo de Barros E Silva, Remo H. M. Furtado, John H. Alexander, and Otavio Berwanger. “Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.” Lancet 398, no. 10308 (October 9, 2021): 1304. https://doi.org/10.1016/S0140-6736(21)01909-7.
Lopes RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, Berwanger O. Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply. Lancet. 2021 Oct 9;398(10308):1304.
Lopes, Renato D., et al. “Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.” Lancet, vol. 398, no. 10308, Oct. 2021, p. 1304. Pubmed, doi:10.1016/S0140-6736(21)01909-7.
Lopes RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, Berwanger O. Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply. Lancet. 2021 Oct 9;398(10308):1304.

Published In
Lancet
DOI
EISSN
1474-547X
Publication Date
October 9, 2021
Volume
398
Issue
10308
Start / End Page
1304
Location
England
Related Subject Headings
- SARS-CoV-2
- Humans
- General & Internal Medicine
- Fibrin Fibrinogen Degradation Products
- COVID-19
- Anticoagulants
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences